Skip to main content
RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc. — Investor Relations & Filings

Ticker · RAPT ISIN · US75382E1091 LEI · 549300MB473BIU78ES48 US Manufacturing
Open in API
Filings indexed 534 across all filing types
Latest filing 2022-06-30 Regulatory Filings
Country US United States of America
Listing US RAPT

About RAPT Therapeutics, Inc.

https://rapt.com/

RAPT Therapeutics, Inc. is a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for patients with inflammatory and immunologic diseases. The company's scientific approach involves developing therapeutics that intelligently target key drivers of the immune system. Its pipeline includes ozureprubart (RPT904), a long-acting anti-IgE antibody being evaluated in a Phase 2b clinical trial for the treatment of food allergies.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings
2022-06-30 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to a 424(b)(3) registration statement, relating to the resale of shares of common stock by a selling stockholder. It details the terms of the offering, the securities involved, risk factors, and corporate information. This type of document is a registration statement prospectus used for capital raising and securities offering purposes. It is not an annual report, earnings release, or management discussion. It is specifically related to capital markets activity and financing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full prospectus, not a brief announcement or a report publication announcement.
2022-06-29 English
Regulatory Filings 2022
Regulatory Filings Classification · 100% confidence The document is a letter from RAPT Therapeutics, Inc. to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-3. It references a registration statement filing and requests SEC action, which is typical of a regulatory filing related to capital markets activity. The document is short (1235 characters) and is a correspondence/request rather than a full report or financial statement. It does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and correspondence with the SEC that do not fit other categories.
2022-06-27 English
Regulatory Filings 2022
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Without any discernible information or context, it is impossible to classify the document as any specific filing type. According to the fallback rule, when a document does not fit any specific category or lacks sufficient information, it should be classified as a Regulatory Filing (RNS). The document length is 15,000 characters, which is substantial, but the content is not interpretable. Therefore, the best classification is RNS with moderate confidence due to lack of readable content.
2022-06-27 English
S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities for public offering. It includes detailed information about the securities being registered, the selling stockholder, and the terms of the offering. The text references the Securities Act of 1933 and discusses the registration of shares for resale by a selling stockholder. This is a capital markets filing related to fundraising and securities registration, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is the registration statement itself, not just an announcement or a certification, so it is not RPA or RNS.
2022-06-24 English
SC 13G
Major Shareholding Notification
2022-06-03 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.